Ignite Creation Date:
2025-12-26 @ 10:34 AM
Ignite Modification Date:
2026-06-03 @ 1:35 AM
Study NCT ID:
NCT04710628
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-07-02
First Post:
2020-12-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination of Pembrolizumab and Lenvatinib, in Pre-treated Thymic CArcinoma paTIents
Sponsor:
MedSIR
Organization: